-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $52

Benzinga·11/02/2026 16:46:05
Listen to the news
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $55 to $52.